Calton & Associates, Inc. Arcturus Therapeutics Holdings Inc. Transaction History
Calton & Associates, Inc.
- $542 Million
- Q2 2025
A detailed history of Calton & Associates, Inc. transactions in Arcturus Therapeutics Holdings Inc. stock. As of the latest transaction made, Calton & Associates, Inc. holds 10,890 shares of ARCT stock, worth $245,678. This represents 0.03% of its overall portfolio holdings.
Number of Shares
10,890Holding current value
$245,678% of portfolio
0.03%Shares
1 transactions
Others Institutions Holding ARCT
# of Institutions
171Shares Held
25.9MCall Options Held
321KPut Options Held
136K-
Federated Hermes, Inc. Pittsburgh, PA4.69MShares$106 Million0.12% of portfolio
-
Black Rock Inc. New York, NY2.65MShares$59.8 Million0.0% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.1.83MShares$41.3 Million0.02% of portfolio
-
Nikko Asset Management Americas, Inc.1.83MShares$41.3 Million0.25% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.81MShares$40.8 Million0.0% of portfolio
About Arcturus Therapeutics Holdings Inc.
- Ticker ARCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,576,400
- Market Cap $600M
- Description
- Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...